Trial intelligence / Profile preview

KETONES ICU

NCT07364162Phase 2Recruiting

Sponsor
Vanderbilt University Medical Center
Start
Jun 2026
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Ketone monoester in delirium, sponsored by Vanderbilt University Medical Center. Started Jun 2026; status: recruiting.

02

Drugs

Ketone monoester
03

Conditions

delirium

Beyond the preview

Go deeper on NCT07364162.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07364162.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call